For as long as I (Max) can remember, I’ve intentionally used the holidays to reflect and write my predictions for the future. This year, AI is a dominant theme, but how can it not be? It’s one of the biggest platform shifts in history. It’s still early, so it should only get even more exciting… →
CONCLUSION: Despite a favorable safety profile, the benefit of treatment with CMVIG to prevent a maternal-fetal CMV transmission could not be demonstrated in our trial. →

CONCLUSIONS: Sleep hygiene education delivered in a primary care setting significantly improved sleep quality and reduced blood pressure levels in patients with essential hypertension. This approach may also help prevent complications related to hypertension. Clinical trial registration: ClinicalTrials.gov (Identifier: NCT07257237; registered on 20 November 2025). →

CONCLUSIONS: Daytime administration of NSAIDs might be sufficient to manage postoperative pain after third molar extraction, and complications were similar between both groups. →

CONCLUSION: The results suggest a durable effect of MBTp. →

CONCLUSION: FCC combined with psychological intervention effectively enhances sleep quality, mitigates anxiety, promotes treatment adherence and improves family satisfaction among children with bronchopneumonia. This provides practical evidence for the application of this comprehensive nursing model in paediatric clinical practice and research in the field of family-centred comprehensive interventions. →

CONCLUSION: The disease-specific QoL scale is valid for assessing patients with early postoperative bowel obstruction. The interactive video health intervention effectively improves their QoL and clinical rehabilitation, providing a feasible clinical tool. →

Life-threatening dyskalemia, defined as an abnormal serum potassium concentration, is common in emergency settings that requires timely recognition and treatment and can be detected via AI-enabled electrocardiography. We conducted a pragmatic, open-label, randomized controlled trial with physician-level randomization to evaluate whether a real-time AI-enabled electrocardiography alert could improve physicians’ management of dyskalemia. Over a six-month… →

CONCLUSIONS: Use of claims data underestimated adverse event rates following colonoscopy. Difference in coding practice across hospitals underscores the need for standardised reporting in screening programmes. →

CONCLUSIONS: Upadacitinib effectively reduced pain in active RA and PsA, including in patients with AoI. The greater pain relief observed in RA with upadacitinib versus adalimumab might indicate both direct (relieving non-inflammatory pain) and indirect (suppressing inflammation) effects. →
